Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hypertension

Free Subscription 09.12.2019 4 Am J Hypertens 1 Am J Med 1 Circulation 1 Curr Opin Nephrol Hypertens 11 Hypertension 2 J Cardiovasc Pharmacol 2 J Hum Hypertens 10 J Hypertens 2 N Engl J Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Hypertens

1. CHOWDHURY EK, Nelson MR, Ernst ME, Margolis KL, et al
   Factors associated with treatment and control of hypertension in a healthy elderly population free of cardiovascular disease: a cross-sectional study.
   Am J Hypertens. 2019 Dec 6. pii: 5661095. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
2. OSTROSKY-FRID M, Chavez-Canales M, Romo M, Grunfeld B, et al
   Familial Hyperkalemic Hypertension Genotype with a Negative Phenotype: a CUL3 mosaicism.
   Am J Hypertens. 2019 Dec 5. pii: 5658471. doi: 10.1093.
   PubMed     Text format    
   
   
3. GHAZI L, Baker JV, Sharma S, Jain MK, et al
   Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial.
   Am J Hypertens. 2019 Sep 6. pii: 5564372. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
4. FISHMAN B, Leiba A, Twig G, Shlomai G, et al
   Ethnic Variability Among Jews is Associated With Hypertension: Results of a Nationwide Study of 1.44 Million Adolescents.
   Am J Hypertens. 2019 Nov 28. pii: 5645035. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Am J Med

5. SHADRIN IY, Idossa D, Walston V, Lee J 3rd, et al
   Pulmonary hypertension and pericardial effusions - to tap or not to tap.
   Am J Med. 2019 Nov 29. pii: S0002-9343(19)30858.
   PubMed     Text format    
   
   

   
   Circulation

6. PETERS SAE, Muntner P, Woodward M
   Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.
   Circulation. 2019;139:1025-1035.
   PubMed     Text format     Abstract available
   
   

   
   Curr Opin Nephrol Hypertens

7. FANG S, Sigmund CD
   PPARgamma and RhoBTB1 in hypertension.
   Curr Opin Nephrol Hypertens. 2019 Nov 27. doi: 10.1097/MNH.0000000000000579.
   PubMed     Text format     Abstract available
   
   

   
   Hypertension

8. NAIDOO S, Kagura J, Fabian J, Norris SA, et al
   Early Life Factors and Longitudinal Blood Pressure Trajectories Are Associated With Elevated Blood Pressure in Early Adulthood.
   Hypertension. 2019;73:301-309.
   PubMed     Text format     Abstract available
   
   
9. KIM MK, Han K, Koh ES, Kim ES, et al
   Blood Pressure and Development of Cardiovascular Disease in Koreans With Type 2 Diabetes Mellitus.
   Hypertension. 2019;73:319-326.
   PubMed     Text format     Abstract available
   
   
10. BRUNO RM, Marais L, Khettab H, Lorthioir A, et al
    Deep Vascular Phenotyping in Patients With Renal Multifocal Fibromuscular Dysplasia.
    Hypertension. 2019;73:371-378.
    PubMed     Text format     Abstract available
    
    
11. KEEFE JA, Hwang SJ, Huan T, Mendelson M, et al
    Evidence for a Causal Role of the SH2B3-beta2M Axis in Blood Pressure Regulation.
    Hypertension. 2019;73:497-503.
    PubMed     Text format     Abstract available
    
    
12. PAPPACCOGLI M, Di Monaco S, Perlo E, Burrello J, et al
    Comparison of Automated Office Blood Pressure With Office and Out-Off-Office Measurement Techniques.
    Hypertension. 2019;73:481-490.
    PubMed     Text format     Abstract available
    
    
13. ZAFARMAND MH, Spanjer M, Nicolaou M, Wijnhoven HAH, et al
    Influence of Dietary Approaches to Stop Hypertension-Type Diet, Known Genetic Variants and Their Interplay on Blood Pressure in Early Childhood: ABCD Study.
    Hypertension. 2019 Dec 2:HYPERTENSIONAHA11812292.
    PubMed     Text format     Abstract available
    
    
14. DOMINICZAK AF, Meyer TJ
    Hypertension: Update 2020.
    Hypertension. 2019 Dec 2:HYPERTENSIONAHA11914352.
    PubMed     Text format    
    
    
15. LLORENS-CORTES C, Touyz RM
    Evolution of a New Class of Antihypertensive Drugs: Targeting the Brain Renin-Angiotensin System.
    Hypertension. 2019 Dec 2:HYPERTENSIONAHA11912675.
    PubMed     Text format     Abstract available
    
    
16. CHAUDHARY NS, Bridges SL Jr, Saag KG, Rahn EJ, et al
    Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study.
    Hypertension. 2019 Dec 2:HYPERTENSIONAHA11913580.
    PubMed     Text format     Abstract available
    
    
17. ITO S, Itoh H, Rakugi H, Okuda Y, et al
    Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study).
    Hypertension. 2019 Dec 2:HYPERTENSIONAHA11913569.
    PubMed     Text format     Abstract available
    
    
18. LU X, Rudemiller NP, Privratsky JR, Ren J, et al
    Classical Dendritic Cells Mediate Hypertension by Promoting Renal Oxidative Stress and Fluid Retention.
    Hypertension. 2019 Dec 2:HYPERTENSIONAHA11913667.
    PubMed     Text format     Abstract available
    
    

    
    J Cardiovasc Pharmacol

19. HUANG Y, Wu X, Wu M, Chu J, et al
    Antihypertensive and Vasodilatory Effects of Qingda Granules by Suppression of Calcium Influx and the AKT Pathway.
    J Cardiovasc Pharmacol. 2019;74:549-557.
    PubMed     Text format     Abstract available
    
    
20. LAHERA V
    Mechanisms Underlying the Antihypertensive and Vasodilatory Effects of Qingda Granules.
    J Cardiovasc Pharmacol. 2019;74:511-512.
    PubMed     Text format    
    
    

    
    J Hum Hypertens

21. KATAMBA G, Collins Agaba D, Migisha R, Namaganda A, et al
    Using blood pressure height index to define hypertension among secondary school adolescents in southwestern Uganda.
    J Hum Hypertens. 2019 Dec 2. pii: 10.1038/s41371-019-0292.
    PubMed     Text format     Abstract available
    
    
22. LUO Q, Li N, Wang M, Yao X, et al
    Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study.
    J Hum Hypertens. 2019 Dec 2. pii: 10.1038/s41371-019-0291.
    PubMed     Text format     Abstract available
    
    

    
    J Hypertens

23. GRAU-PEREZ M, Redon J
    Unraveling new factors associated with hypertension: the Mendelian randomization approach.
    J Hypertens. 2020;38:30-32.
    PubMed     Text format    
    
    
24. TOCCI G, Presta V, Volpe M
    Hypertensive crisis management in the emergency room: time to change?
    J Hypertens. 2020;38:33-34.
    PubMed     Text format    
    
    
25. FEITOSA ADM, Mota-Gomes MA, Barroso WS, Miranda RD, et al
    Correlation between office and home blood pressure in clinical practice: a comparison with 2017 American College of Cardiology/American Heart Association Hypertension Guidelines recommendations.
    J Hypertens. 2020;38:179-181.
    PubMed     Text format    
    
    
26. HAN M, Chen Q, Liu L, Li Q, et al
    Stage 1 hypertension by the 2017 American College of Cardiology/American Heart Association hypertension guidelines and risk of cardiovascular disease events: systematic review, meta-analysis, and estimation of population etiologic fraction of prospect
    J Hypertens. 2019 Dec 4. doi: 10.1097/HJH.0000000000002321.
    PubMed     Text format     Abstract available
    
    
27. UIJL E, 't Hart DC, Roksnoer LCW, Clahsen-van Groningen MC, et al
    Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury.
    J Hypertens. 2019 Dec 4. doi: 10.1097/HJH.0000000000002326.
    PubMed     Text format     Abstract available
    
    
28. FEITOSA ADM, Mota-Gomes MA, Barroso WS, Miranda RD, et al
    Relationship between office isolated systolic or diastolic hypertension and white-coat hypertension across the age spectrum: a home blood pressure study.
    J Hypertens. 2019 Nov 28. doi: 10.1097/HJH.0000000000002320.
    PubMed     Text format     Abstract available
    
    
29. CUSPIDI C, Facchetti R, Quarti-Trevano F, Sala C, et al
    Left ventricular mass and incident out-of-office hypertension in a general population.
    J Hypertens. 2019 Nov 26. doi: 10.1097/HJH.0000000000002313.
    PubMed     Text format     Abstract available
    
    
30. SHARMAN JE, O'Brien E, Alpert B, Schutte AE, et al
    Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure.
    J Hypertens. 2020;38:21-29.
    PubMed     Text format     Abstract available
    
    
31. BARANOWSKA-KUCZKO M, Kozlowska H, Kloza M, Sadowska O, et al
    Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities.
    J Hypertens. 2019 Dec 2. doi: 10.1097/HJH.0000000000002333.
    PubMed     Text format     Abstract available
    
    
32. CAMELI M, Lembo M, Sciaccaluga C, Bandera F, et al
    Identification of cardiac organ damage in arterial hypertension: insights by echocardiography for a comprehensive assessment.
    J Hypertens. 2019 Dec 4. doi: 10.1097/HJH.0000000000002323.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

33. CHRISTIANSEN SC, Zuraw BL
    Treatment of Hypertension in Patients with Asthma. Reply.
    N Engl J Med. 2019;381:2279.
    PubMed     Text format    
    
    
34. LIN CH
    Treatment of Hypertension in Patients with Asthma.
    N Engl J Med. 2019;381:2278-2279.
    PubMed     Text format    
    
    

    
    PLoS One

35. NAGAI K, Yamagata K, Iseki K, Moriyama T, et al
    Antihypertensive treatment and risk of cardiovascular mortality in patients with chronic kidney disease diagnosed based on the presence of proteinuria and renal function: A large longitudinal study in Japan.
    PLoS One. 2019;14:e0225812.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: